Blinding and Firewalls in Interim Data Access During Clinical Trials
Blinding and Firewalls in Interim Data Access During Clinical Trials Blinding and Firewalls in Interim Data Access During Clinical Trials Blinding and firewall mechanisms are essential safeguards in clinical trials, particularly during interim analyses. These controls ensure that interim data do not influence the conduct of the trial or introduce bias into decision-making by the…
Read More “Blinding and Firewalls in Interim Data Access During Clinical Trials” »